Allele HLA-DQB1*06 reduces fibrosis score in patients with non-alcoholic fatty liver disease.

Tan, Hwa-Li; Zain, Shamsul Mohd; Eng, Hooi-Sian; Mohamed, Zahurin; Mahadeva, Sanjiv; Chan, Wah-Kheong; Lau, Peng-Choong; Basu, Roma Choudhury; Mohamed, Rosmawati

Tan, Hwa-Li; Zain, Shamsul Mohd; Eng, Hooi-Sian; Mohamed, Zahurin; Mahadeva, Sanjiv; Chan, Wah-Kheong; Lau, Peng-Choong; Basu, Roma Choudhury; Mohamed, Rosmawati.

Afiliação

Tan HL; Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Zain SM; Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Eng HS; Nephrology and Transplantation Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Mohamed Z; Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Mahadeva S; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Chan WK; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Lau PC; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Basu RC; Clinical Investigation Centre, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Mohamed R; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Hepatol Res ; 50(8): 947-954, 2020 Aug.

Article em En | MEDLINE | ID: mdl-32410320

Palavras-chave

HLA-DQ; NAFLD; NASH; fatty liver; fibrosis; human leukocyte antigen

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Hepatol Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Malásia